Skip to main content

Table 3 Associations of comorbidities/medications with monitoring tests

From: Safety monitoring of treatment in bipolar disorder in a tertiary care setting in Sri Lanka and recommendations for improved monitoring in resource limited settings

Factor or medication used

Monitoring

p

Diabetes

Fasting blood glucose test in the last year

<0.001

Hypothyroidism

TSH testing in the past year

<0.001

Hypercholesterolemia

Lipid profile testing in the past year

<0.001

Lithium

TSH testing in the past year

<0.05

Lithium

Serum urea or creatinine testing in the past year

<0.05

Having a disease exacerbation in the past year

Lithium monitoring in the past year

>0.05

Valproate

Liver function tested in the past year

>0.05

Atypical antipsychotics

Fasting blood glucose test in the last year

>0.05

Atypical antipsychotics

Lipid profile testing past year

>0.05